Stereochemistry | ABSOLUTE |
Molecular Formula | C19H28N2O7S2 |
Molecular Weight | 460.565 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OS(N)(=O)=O)C=C2CC[C@H]3[C@@H]4CC[C@H](OS(N)(=O)=O)[C@@]4(C)CC[C@@H]3C2=C1
InChI
InChIKey=AQSNIXKAKUZPSI-SSTWWWIQSA-N
InChI=1S/C19H28N2O7S2/c1-19-8-7-12-13(15(19)5-6-18(19)28-30(21,24)25)4-3-11-9-17(27-29(20,22)23)16(26-2)10-14(11)12/h9-10,12-13,15,18H,3-8H2,1-2H3,(H2,20,22,23)(H2,21,24,25)/t12-,13+,15-,18-,19-/m0/s1
Molecular Formula | C19H28N2O7S2 |
Molecular Weight | 460.565 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
39.0 nM [IC50] | |||
379.0 nM [IC50] |